Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
AstraZeneca

Last Updated: May 26, 2022

PTAB Cases from Fresenius Kabi USA, LLC


✉ Email this page to a colleague

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: Fresenius Kabi USA, LLC

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
10,155,039 Fresenius Kabi USA, LLC See Plans and Pricing 2019-09-17 09-25-2019 Manning et al Post-grant review See Plans and Pricing 03-19-2020 See Plans and Pricing
8,114,833 Fresenius Kabi USA, LLC See Plans and Pricing 2022-03-03 03-03-2022 Pedersen et al Inter partes review See Plans and Pricing See Plans and Pricing
8,242,158 Fresenius Kabi USA, LLC See Plans and Pricing 2017-03-08 03-08-2017 Cedergren Roychowdhury et al Inter partes review See Plans and Pricing 09-06-2017 See Plans and Pricing
8,329,680 Fresenius Kabi USA, LLC See Plans and Pricing 2017-08-04 08-04-2017 Evans et al Inter partes review See Plans and Pricing 12-11-2017 See Plans and Pricing
8,338,470 Fresenius Kabi USA, LLC See Plans and Pricing 2017-03-08 03-08-2017 Cedergren Roychowdhury et al Inter partes review See Plans and Pricing 09-06-2017 See Plans and Pricing
8,455,527 Fresenius Kabi USA, LLC See Plans and Pricing 2017-03-08 03-08-2017 Cedergren Roychowdhury et al Inter partes review See Plans and Pricing 09-06-2017 See Plans and Pricing
8,466,139 FRESENIUS KABI USA, LLC See Plans and Pricing 2017-08-04 08-04-2017 Evans et al Inter partes review See Plans and Pricing 12-11-2017 See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
Colorcon
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.